Home / Tools / GLP-1 eligibility checker
Relationship Disclosure: Semaglutide Watchdog and its publisher, US Peptides Partners LLC, have no ownership, affiliate, referral, advertising, management, reviewer, or other material financial relationship with certain providers listed on this website. All providers are evaluated using the same documented evidence, pricing, and verification methodology, regardless of relationship status.
Written by Kim Callender, NP, FNP-BC·Published July 12, 2026·Last reviewed July 12, 2026·Methodology v1.0

GLP-1 eligibility checker

An educational self-check of common GLP-1 eligibility factors. Not a diagnosis or guarantee of treatment.

Not medical adviceResults are informational only and are not a diagnosis, a prescription, or a guarantee of treatment eligibility. A licensed clinician determines whether treatment is appropriate.

This is an educational self-check, not a medical assessment. Only a licensed clinician can determine eligibility.

Meeting these does not guarantee a prescription; a clinician reviews your full history.

SURMOUNT-1 — mean body-weight reduction by tirzepatide dose, 72 weeks
06111723Placebo3%Tirzepatide 5mg15%Tirzepatide 10mg20%Tirzepatide 15mg21%

Jastreboff AM et al., N Engl J Med 2022 (NCT04184622), n=2,539. Dose-response is real: the effect rises with dose. These are FDA-APPROVED SUBCUTANEOUS INJECTION doses — they do not transfer to compounded, microdose or ODT products. Trial means are not individual promises.

What this tool calculates, and the formula behind it

Every figure this tool produces uses the same formula as our editorial pages, drawn from the same dataset. There is no separate “marketing” number.

Effective monthly cost = total mandatory payments ÷ months supplied.

Inputs, and why each one is in the formula
InputWhy it counts
Advertised priceThe starting point — and usually the most misleading number available.
Number of monthsA 12-month plan and a month-to-month plan are not the same product.
Membership feeIf you cannot decline it, it is part of the price. Roughly half the market splits it out.
Consultation feeCharged separately by some providers; invisible in most comparison tables.
Laboratory feeSome programmes require labs and bill them; others include them.
ShippingFree at some providers, billed at others.
Onboarding feeA one-off charge that is amortised across the plan, not ignored.
Dose surchargeThe big one. A flat-rate programme and an escalating one can differ by thousands a year at maintenance.
Renewal priceWhat you pay from month two. This is the number that matters.
Discount / couponApplied only where the eligibility is stated.

Assumptions and limitations

Privacy

This tool runs entirely in your browser. Nothing you enter is transmitted, stored or logged. We do not collect health information through any tool, form or search on this site.

Frequently asked questions

Are these prices verified?

Provider prices shown in our tools are captured from provider sites and major publishers and labeled with a verification status and date. Only first-party captures are marked Verified; always confirm current pricing on the provider’s own site before enrolling.

Does this tool give medical advice?

No. Our calculators and checklists are educational and help you compare cost and program features. Eligibility and treatment decisions are made by a licensed clinician.

How is effective monthly cost calculated?

Total mandatory payments for the treatment period — medication plus required membership, labs, shipping, onboarding, and dose surcharges — divided by months supplied. See our affordability methodology.

What this eligibility checker does and does not do

This checker reflects the general clinical thresholds most telehealth programs and FDA labels use: a body mass index of 30 or higher, or 27–29.9 with at least one weight-related condition such as type 2 diabetes, hypertension, or obstructive sleep apnea. It provides an educational indication of whether you may meet common eligibility criteria.

Why only a licensed clinician can determine eligibility

Meeting a BMI threshold is necessary but not sufficient. A licensed provider must review your full medical history, current medications, and contraindications — including a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2, pancreatitis, and pregnancy — before determining whether semaglutide is appropriate. This tool cannot make that determination and does not establish a provider-patient relationship. Eligibility is decided by a clinician, not by a calculator.

Limitations

The thresholds shown are general and may differ by program, state, and indication. Some programs use a BMI floor as low as 27 with a comorbidity; others require higher. This tool does not collect or store the values you enter, provides no diagnosis, and is not a substitute for professional medical evaluation. Last reviewed July 2026.